Avenell A., Cook J.A., MacLennan G.S., McPherson G.C. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age and Ageing 2009, 38(5):606-609.
Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: perspectives from mice and man. Journal of Bone and Mineral Research 2008, 23(7):974-979.
Cantorna M.T., Hayes C.E., Deluca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. The Journal of Nutrition 1998, 128(1):68-72.
Holick M.F. Vitamin D deficiency. The New England Journal of Medicine 2007, 357(3):266-281.
Ishii H., Suzuki H., Baba T., Nakamura K., Watanabe T. Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care 2001, 24(8):1503.
Jorde R., Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. European Journal of Nutrition 2009, 48(6):349-354.
Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. The American Journal of Clinical Nutrition 2007, 85(6):1586-1591.
Lemire J.M., Ince A., Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992, 12(2):143-148.
Liang W.W. Seasonal changes in preprandial glucose, A1C, and blood pressure in diabetic patients. Diabetes Care 2007, 30(10):2501-2502.
Mathieu C., Waer M., Casteels K., Laureys J., Bouillon R. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 1995, 136(3):866-872.
Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association 2006, 296(23):2832-2838.
Nagpal J., Pande J.N., Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabetic Medicine 2009, 26(1):19-27.
Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. The Journal of Clinical Endocrinology and Metabolism 2001, 86(4):1633-1637.
Pittas A.G., Dawson-Hughes B., Li T., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29(3):650-656.
Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30(4):980-986.
Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism 2007, 92(6):2017-2029.
Scragg R., Holdaway I., Singh V., Metcalf P., Baker J., Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Research and Clinical Practice 1995, 27(3):181-188.
Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27(12):2813-2818.
Snijder M., Van Dam R.M., Visser M., Deeg D., Seidell J., Lips P. To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247-1257. Diabetologia 2006, 49(1):217-218.
Souberbielle J.C., Body J.J., Lappe J.M., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmunity Reviews 2010, 9(11):709-715.
Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine 2008, 25(3):320-325.
Tai K., Need A.G., Horowitz M., Chapman I.M. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008, 24(10):950-956.
Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. The American Journal of Clinical Nutrition 2010, 91:1255-1260.
Visser M., Deeg D.J., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. The Journal of Clinical Endocrinology and Metabolism 2003, 88(12):5766-5772.
von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. The British Journal of Nutrition 2010, 103(4):549-555.
Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
Wareham N.J., Byrne C.D., Carr C., Day N.E., Boucher B.J., Hales C.N. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997, 46(10):1171-1177.
Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53(10):2112-2119.
Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Korfer R., Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. Journal of the American College of Cardiology 2003, 41(1):105-112.